Berger, N. A., Besson, V. C., Boulares, A. H., Bürkle, A., Chiarugi, A., Clark, R. S., . . . Szabo, C. (2017). Opportunities for the repurposing of PARP inhibitors for the therapy of non‐oncological diseases. Br J Pharmacol.
Chicago Style CitationBerger, Nathan A., et al. "Opportunities for the Repurposing of PARP Inhibitors for the Therapy of Non‐oncological Diseases." Br J Pharmacol 2017.
Cita MLABerger, Nathan A., et al. "Opportunities for the Repurposing of PARP Inhibitors for the Therapy of Non‐oncological Diseases." Br J Pharmacol 2017.
Atenció: Aquestes cites poden no estar 100% correctes.